Hepatitis C

Under USAID’s EQUIP project, led by Right to Care in South Africa, we estimated the costs of providing effective treatment for hepatitis C (HCV) in Ukraine and Myanmar. Our results and other relevant publications are listed below.

Publications and Documents

Impact of direct-acting antiviral treatment of hepatitis C on the quality of life of adult patients in Ukraine. Benade M, Rosen S, Antoniak S, Chasela C, Stopolianska Y, Barnard T, Gandhi MM, Ivanchuk I, Tretiakov V, Dible J, Minior T, Chew KW, van der Horst C, Tsenilova Z, Sanne I.  BMC Infect Dis. 2022 Jul 27;22(1):650. doi: 10.1186/s12879-022-07615-9. PMID: 35896987; PMCID: PMC9330669.

Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among HCV and HIV co-infected patients in Ukraine. Antoniak S, Chasela CS, Freiman MJ, Stopolianska Y, Barnard T, Gandhi MM, Liulchuk M, Tsenilova Z, Viktor T, Dible J, Wose Kinge C, Akpan F, Minior T, Sigwebela N, Mohamed S, Barralon M, Marange F, Cavenaugh C, Horst CV, Antonyak S, Xulu T, Chew KW, Sanne I, Rosen S; for EQUIP Health.  JGH Open. 2022 Nov 17;6(12):894-903. doi: 10.1002/jgh3.12839. PMID: 36514496; PMCID: PMC9730727.

Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus co-infected patients in Myanmar. Thaung YM, Chasela C, Chew K, Minior T, Thwin A, Bijl M, Mohamed S, Naiing a, Wose Kinge C, Sein YY, Drame N, Marange F, van der Horst C, Thwin H, Freiman M, Gandhi M, Thura S, Xulu T, Barralon M, Cavanaugh C, Rosen S, Kyi K, Sanne I.  Viral Hepat. 2021 Jan;28(1):147-158. doi: 10.1111/jvh.13405. Epub 2020 Oct 9. PMID: 32935438; PMCID: PMC7746582.

Report on cost of HCV treatment and monitoring tests in Ukraine (August 2019).

Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving. Popping S, Nichols B, Rijnders B, van Kampen J, Verbon A, Boucher C, van de Vijver D. J Virus Erad. 2019 Nov 4;5(4):179-190. doi: 10.1016/S2055-6640(20)30031-5. PMID: 31754441; PMCID: PMC6844408.